Avaxia Biologics' Debt Round

Avaxia Biologics raised a round of funding on May 06, 2014.

Avaxia is an early-stage biotechnology company focused on developing recombinant, gut-targeted antibody therapeutics for gastrointestinal diseases. These unique antibody therapeutics, called Avaximabs…

Articles about Avaxia Biologics' Debt Round: